Read + download the full collection of #ASGCTBreakthroughs24 abstracts ahead of our inaugural muscular dystrophy conference Nov. 19-20.
Tom McCauley, PhD (Omega Therapeutics) joins Emily Walsh Martin, PhD to explore the next generation of molecular therapeutics on the second episode of The Issue, available now on the ASGCT Podcast Network.
Follow the ASGCT Podcast Network wherever you listen to podcasts!
Episode 2 of The Issue on the ASGCT podcast network is an in-depth interview with Tom McCauley, PhD, CSO of Omega Therapeutics. Tom and Emily talk about his path from condensed matter physics to leading teams of scientists exploring the next generation of molecular therapeutics. They also dive into their mutual experience in the early days of in vivo gene editing and the challenges one faces with the complexities of these products, particularly before there is much of a roadmap for development. Finally, they dive into the recent public Ad Comm and ultimate approval of Casgevy and how we hope the industry continues to evolve and set standards as we move forward novel approaches.
Music by: https://www.steven-obrien.net/ -------------------------- Bright New Morning - Steven O'Brien
(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico